Nugg is one of the hottest startups in the $30-50 billion marijuana space. If you’re passionate about joining a dynamic company that is already a leader in it’s industry (and has massive growth potential), Nugg is the right place for you!
We are seeking a cannabis connoisseur to support our efforts to offer personalized online assistance and expert knowledge to customers in ways that improve their cannabis experience.
Please don’t apply to this job if you do not meet the qualifications listed below. We still love you, but we owe it to our customers to make sure these new hires are truly cannabis experts.
Hours & Location:
This is a full-time (~40 hours/week) remote, online position. Our entire team is remote, but we have an office in Marina Del Rey that you’re free to work at as much as you like. This is an independent contractor position to start.
Starts at $15/hr, with quarterly raises based on performance.
provide expert, science-backed cannabis knowledge to online Nugg customers that have questions about how to improve their cannabis experience
help customers (in a timely, professional, and friendly fashion) using our delivery marketplace find the products and dispensaries that best fit their preferences
constantly stay up to date with the latest cannabis-related research studies and findings, and integrate this new knowledge into how we help customers
recruit, train, and manage a team of customer service representatives capable of offering the same level of cannabis expertise that you yourself offer customers
you are a cannabis expert; you have complete knowledge on such topics as 1) the science of cannabis 2) different consumption methods, manufacturing processes, and the pros and cons of each 3) how medical cannabis is best used for different symptoms and ailments 4) much more
capable of articulating this knowledge in ways that make it easy for customers to digest and practically apply to their cannabis experience
exceptional typist; you type 65+ wpm
exceptional communication skills and professional presence
innovative problem solver, results minded and solution focused
effective team player with ability to work independently
tech savvy, strong in multi-tasking between different programs and communications
you love helping people and making people smile
understanding of how the medical marijuana market works in California
Based in Los Angeles, we’re the nation’s largest online cannabis marketplace. We provide quick, easy, and professional access to medical marijuana delivery for people in California, and have ambitious plans to offer our services throughout the entire United States.
The other arm of our business, NuggMD, is the nation’s leading telemedicine platform for cannabis, connecting potential cannabis users with licensed doctors via live video to make getting a doctor’s recommendation for medical cannabis quick and painless.
NuggMD is the leading telemedicine platform for cannabis evaluations, has served over 100,000 people in California and New York, and will be available in more states soon.
Benefits & Culture:
We’re a half-remote, half Los Angeles local team, and that’s just the way we like it. At Nugg, you can work whenever, wherever, however, as long as you get your shit done. We’re a laid-back team that enjoys ping pong, Saturday brunch, the outdoors, house music, and the little things in life.
As our newest team member, you’ll be given full autonomy to execute on your ideas. You’ll get as many vacation days as you want. At Nugg, you’ll have boatloads of fun, while testing the limits of your expertise and innovative capacities. At Nugg, life gets a little better each day.
To date, 44 states and territories, including D.C., Guam and Puerto Rico, have passed laws allowing the use of medical marijuana in one form or another. Our President promised during his campaign trail that he would respect state’s rights concerning this issue and leave enforcement in the hands of local governments.
Yet the industry is now growing more and more concerned over recent comments from Trump’s new pick for Attorney General, Jeff Sessions. Will Trump keep his promises? Does the administration even have the power to stop the full-speed legalization train even if they wanted to? What can the Congressional Cannabis Caucus do to secure a better future for cannabis?
Keep reading to find out or click on one of these topics:
What you will learn in this post:
(Click any of the section titles below to jump right to it)
Yes, those who live in legal cannabis states are wondering how safe their investments are. And it’s a fair concern. After all, much of the conversation from GOP stalwarts surrounding legalization is focused on the old knee-jerk arguments from the Reagan Era drug war, statements that have now been proven shockingly false.
For instance, Sessions released a statement just over a week agosaying, “I reject the idea that America will be a better place if marijuana is sold in every corner store. And I am astonished to hear people suggest that we can solve our heroin crisis by legalizing marijuana–so people can trade one life-wrecking dependency for another that’s only slightly less awful. Our nation needs to say clearly once again that using drugs will destroy your life.”
More than 33,000 people died from prescription opioids and illegal heroin in 2015. Roughly half of these deaths were from doctor prescribed medicine.
Yet in the states that have recently legalized medical marijuana use, those deaths have already been reduced by25 percent.
The lack of scientific and epidemiological understanding in our nation’s leaders is staggering. But how many times can cannabis advocates keep saying that marijuana has never killed a single person and has saved quite a few lives? Till they’re blue in the face? What can you do in the face of such a colossal lack of logical thinking and basic understanding?
The Economic Discussion
According to a recent report from Arcview, legal cannabis sales neared $7 billion in 2014. That’s a whole lot of economy.
Thousands of people have put their life savings into starting new businesses and creating jobs while working with cooperative administrations that realize regulation works best. Some of these companies employ hundreds of people and pay taxes, fees and licenses. In Colorado, for fiscal year 2017 alone, this tax, fee and license income totaled $144,820,374; incidentally a $47 million increase from the year before.
So, the better question might be, how would the Trump administration convince states that are seeing the economic and health benefits of legalization (tax revenue, higher employment, law enforcement savings) to give them up?
It might be safe to assume that the federal government doesn’t have a chance in hell of convincing any legal state to accept the negative rhetoric any more. But four members of Congress aren’t taking any chances.
Meet the Congressional Cannabis Caucus
Pot rights powerhouses Rep. Dana Rohrabacher (R) and Rep. Earl Blumenauer (D) have established a new Congressional Cannabis Caucus to fight for more sensible drug laws from the start of the Trump administration. The two other founding members are Rep. Don Young (R) and Rep. Jared Polis (D).
Polis summed up the reasoning behind their decision to form this caucus, saying:
I think, all four of us, we don’t want to be in a place where we are relying on the goodwill of which side of the bed any attorney general wakes up on in any given day. That’s why we’re pursuing statutory changes.
Respect State Marijuana Laws: Third Time’s a Charm?
This bill, currently listed under H.R. 975, is short, sweet and to the point. It’s a one sentence amendment to Part G Sec. 710 of the Controlled Substances Act, which reads:
Notwithstanding any other provision of law, the provisions of this subchapter related to marijuana shall not apply to any person acting in compliance with State laws relating to the production, possession, distribution, dispensation, administration, or delivery of marihuana.
That’s it. The entire bill in its current form. But this tiny paragraph could literally change drug law in the nation forever and prevent Sessions from moving against the legal states.
When introducing H.R. 975 to congress in January, Rep. Rohrabacher said:
It’s a travesty that we don’t know what marijuana can be positively used for or what the negative impact is because we haven’t done the research. That is a travesty. It’s a travesty when our veterans come home and they’re given opiates…and our veterans end up killing themselves because now they’re addicted to an opiate.
Unfortunately so far, it’s only been referred to committee by default, the graveyard where 96% of all bills go to die. Currently the bill has 8 Democrat and 8 Republican cosponsors, but cosponsors aren’t necessarily a predictor of success. Bipartisan cosponsors, on the other hand, are a very good sign. Also, so is buzz in the media.
One of the biggest buzz points for this bill is that it makes banking for cannabis businesses possible, thus enabling the 46 additional billion dollars in black market sales to safely enter the legal tax revenue stream.
This is becoming a very tempting point for many lawmakers, even though this same bill has failed to move forward twice before. But Members of Congress need encouragement from constituents to sponsor pro-cannabis bills considering the opposition they face from establishment members—people they deal with on a daily basis.
The McClintock-Polis Amendment
Meanwhile, Rep. Polis and Rep. McClintock are planning to prevent Sessions from initiatingrecently-threatened raids and prosecutions by reintroducing the McClintock-Polis Amendment. Meant to become a rider attached to the new federal budget, it can get past a hurdle that most other bills fail to navigate because it’s simply added to a bill that has to pass.
The amendment does much of the same as the successfulRohrabacher-Farr Amendment, as it prevents the federal government from enforcing federal marijuana laws in states that approve the use of marijuana.
But the Rohrabacher-Farr Amendment merely prevents the federal government from spending money on marijuana enforcement in legal states, while the McClintock-Polis Amendment differs by preventing the federal government from arresting and prosecuting people for use, possession or sale of marijuana where it’s legal.
The McClintock-Polis Amendment failed to pass in 2015, even though the Rohrabacher-Farr Amendment did in 2014, and has been renewed each year since then (both must pass every year to remain in effect).
This may be partly due to the fact that Congress felt comfortable passing a budget-saving amendment that prevents the federal government from wasting money but doesn’t tie federal prosecutors’ hands. However, the amendment may stand more of a chance moving forward in the current political environment with constituent encouragement.
Does This Uncertainty Mean Cannabusiness Investments Are a No-Go for Now?
Not necessarily. Sessions would still have to explain his reasoning for prioritizing expensive prosecutions against cannabusiness in legal states when the federal government is already dealing with budget problems. Even Sessions had toadmit, “It’s not possible for the federal government, of course, to take over everything the local police used to do in a state that’s legalized it.”
True, it’s possible that the industry is overreacting to Sessions’ hostility toward cannabis. One must admit, it’s very difficult to enforce a law that most people think is wrong. After all, how would you find a jury willing to convict? How do you enforce it in a state where local police are forced by law not to cooperate with federal authorities during raids?
This isn’t to say that Sessions wouldn’t go after some low hanging fruit by encouraging other agencies like the IRS or FDA to go after quasi-regulated cannabis activities. It’s also been theorized that he may order state attorneys generals to crack down, but would they cooperate?
Furthermore, the Cole Memo is still in place. The memo was written in 2013 by then Deputy Attorney General, James Cole, which prioritized prosecution of marijuana offenses around 8 points, focusing mainly on public health and safety concerns. It also acknowledged that prosecution of medical marijuana in states where it’s legal shouldn’t be a priority if it’s not interfering with these 8 public safety considerations.
Unfortunately, it’s an ambiguous enough document that if Sessions were to carry through with his comment that he “may have some different ideas [himself] in addition to that,” he certainly has the power to act.
So What Can You Do?
Industry experts, activists and patients agree that this is a very dangerous time to rest one one’s laurels and become lax with activism. After all, any perception of flagging support from the populous could give misguided leaders the opportunity they think they need to restart the drug war.
So, it’s recommended that you, all medical marijuana patients and supporters, take a couple minutes a week to use the messages in the links below to inform your U.S. Congressional and Senate representatives of their support. It’s easy and only takes a couple of clicks.
Any congress member can join the Congressional Cannabis Caucus; the more members it has, the more power it gains to pass legislation. Wide support from a large congressional caucus with many members can change the 96% possibility that a bill will fail into a near certainty that it will pass.
New York, NY:On April 18, NuggMD, the California-based leading telemedicine portal that connects qualified medical marijuana patients with licensed physicians online, extends their services across New York. They are the first company to put forth a bold effort to combat the policies that currently severely restrict access to medical cannabis, despite it being legal in the state.
What you'll learn in this post:
[Click any of the section titles below to jump there]
In 2016, NuggMD assisted more than 40,000 California patients to obtain an online medical marijuana consultation with a licensed physician and with their launch, the company is excited to enable participating New York physicians to provide convenient and efficient care to patients statewide.
In March 2015, New York passed the New York Telehealth Amendment Act (Senate Bill 2405), allowing doctors and nursing practitioners in the state to provide medical care and issue medical marijuana certifications 100% online using telehealth/telemedicine technology. With this, New York became one of the five states that does not require an in-person physical examination, to establish a bona fide patient-physician relationship.
However, unlike in California, doctors in New York are required to register for the NYS Medical Marijuana Program and obtain a special certification in order to prescribe medical marijuana making access to care extremely limited. Out of 110,000 practitioners in New York, only 884 are registered for the NYS Medical Marijuana Program.
“Although New York approved medical marijuana in 2014; barely 14,000 people legally have access to it because of restrictions on the visibility and number of doctors. This is a trend we’ve seen across the board in states with new marijuana laws on the books. Access should be feasible, but it’s not, and we’re going to change that; our network of cannabis-expert doctors will accelerate that change better than anyone else,” says Collin Mann, CEO at NuggMD.
To make matters worse, the state Health Department refuses to release certified marijuana doctors’ names, keeping the potentially life-saving medicine out of reach for many who need it. Many patients find themselves 100 miles away from the nearest certified doctor, making it impossible to get the treatment they need.
“It’s frustrating that we can’t find a practitioner, especially while knowing that children in different states have full access to this medicine” stated Dr. Amy Piperato, a doctor in NY whose daughter has epilepsy (video). This is why NuggMD has come to change the situation by extending its services to New York State.
Qualifying Conditions for Cannabis in New York
In NYS, several ailments qualify for Medical Marijuana; these include cancer, HIV infection or AIDS, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, and Huntington’s disease.
On December 1, 2016, the NYS Health Commissioner; Dr. Howard A. Zucker; announced thatchronic pain will be added among the other qualifying conditions for medical marijuana, and now it HAS been added as of March, 2017. Finally, a sign that New York is finally on its way to granting true access to medical cannabis for patients who need it.
NuggMD is California’s largest cannabis marketplace, facilitating access to cannabis in every major metropolitan area (and then some) statewide. It lets anyone consult with a marijuana doctor and order products online from dispensaries that deliver straight to them in under an hour. NuggMD is currently in the process of expanding its business nationwide, beginning with the expansion into New York starting in April.
Terpenes are organic hydrocarbons (among the hundreds of chemical compounds found in cannabis) that plants manufacture and which act as a defense mechanism to deter herbivores (deer or insects) from eating them. Some terpenes even attract species of predators who naturally feed on plant herbivores. Science, right?
Terpenes work because they emit a strong aroma. They are frequently used as the basis of fragrances and flavorings in a wide variety of organic products. For example, the distinctive smell of lavender, mint, or marijuana is entirely due to the unique makeup of terpenes and flavonoids in each of these plant species.
Like cannabinoids such as THC and CBD, terpenes interact with neural and cellular receptors. In particular, they can modulate neurotransmitter levels. By binding to receptors in the brain, terpenes can inhibit the breakdown of serotonin (a feel-good neurotransmitter) or boost dopamine activity (the neurotransmitter that regulates pleasure, motivation, and reward).
THC, because of its psychoactive properties, has received the most interest from researchers. Likewise, CBD has attracted noticeable attention because of its effects on the body’s endocannabinoid system. In contrast, terpenes remain comparatively understudied and unappreciated, but preliminary evidence suggests they’re a much larger piece of the marijuana equation than we currently think.
Useful Facts About Terpenes
Despite our limited understanding of them, here are some intriguing things we do know about the terpenes in cannabis:
Scientists have identified no less than 120 terpenes in marijuana.
About 10 to 30% of cannabis resin consists of terpenes.
The terms “terpenes” and “terpenoids” are often used interchangeably. However, terpenoids are terpenes that have been chemically modified by curing or oxidation.
Terpenes are responsible for pot’s distinctive odor; it’s what drug-sniffing dogs zero in on.
Synthetic forms of marijuana — such as Marinol — lack terpenes, which may explain why many patients find Marinol so ineffective as a medicine.
The terpenes in cannabis are often virtually identical to those found in other plants.
Most of the scientific and medical interest in terpenes has centered on their synergistic effects. For example, Dr. Ethan Russo has specifically called attention the so-called “entourage effect,”which refers to the way that the various compounds in cannabis work together and reinforce each other.
More specifically, the presence of terpenes in marijuana can actually inhibit THC’s intoxicating effects. However, as Dr, Russo notes, the modulation of THC actually serves to increase marijuana’s “therapeutic index” meaning that an inhibition of THC’s effects can actually produce more medical value for you, the consumer.
The dissatisfaction most patients experience with Marinol, a synthetic form of THC, illustrates shortcomings that stem from ignoring the entourage effect. Put simply, many patients find that the isolated concentrations of THC (meaning it lacks terpenes and any other cannabinoids) in Marinol produce a very unpleasant, ineffective experience.
In fact, cannabis researchers believe that both terpenes and cannabinoids like CBD work to modulate THC’s effects. In particular, the presence of terpenes and compounds like CBD are thought to lessen anxiety while boosting THC’s analgesic (pain-relieving) properties, among other effects.
This “phytocannabinoid-terpenoid synergy,” according to Dr. Russo, is the key to marijuana’s extraordinary versatility and effectiveness as a medicine, and is something we’re excited to learn more about as new research is conducted.
In a word, the marijuana plant as a whole is more beneficial than the sum of its constituent parts. With terpenes in the mix, you get more bang for your buck.
Flavonoids in Cannabis
Flavonoids are nutrients that give many plants their distinctive colors. For example, flavonoids are the compounds that give blueberries their vibrant hue. There’s already over 6,000 identified flavonoids known to scientists, and over 20 are found to exist in cannabis. In particular, they are noted for their nutritive, anti-inflammatory, and antioxidant properties. The role they play in marijuana’s therapeutic effects is not well-known, but like terpenes, they are believed to have a synergistic influence.
Only time will tell, as clinical studies will hopefully be possible in the not-too-distant future, once cannabis is removed from the federal list of Schedule I substances.
Choosing Cannabis Strains Based on Terpene Profiles
Terpenes are the building blocks of cannabinoids, plant hormones, and pigments. So, they naturally play a huge role in marijuana’s overall psychological and physical effects. Of course, terpene concentrations and configurations will vary considerably from strain to strain and even batch to batch. Environmental conditions and curing methods will also have a tremendous impact on terpene qualities.
Many medical marijuana patients select specific strains by their scent. There is a sound basis for this. Different terpene concentrations have unique fragrances and medicinal properties. For example, anecdotal reports suggest that strains with a musk or clover scent provide relaxing and sedative effects. In contrast, pot with a piney scent is known for promoting mental alertness and boosting memory. And weed with a lemony scent is renowned for its mood-elevating qualities.
The following are a few of the better-known terpenes along with their characteristics, the medical effects that they’re known for, and some typical strains you can find to match:
Musky aroma. It’s normally found in fruit, but it is the most common terpene found in cannabis too. It is believed to quicken and intensify pot’s psychoactive properties. It is also known for its painkilling, sedative, and insomnia-fighting properties.
Medical Value: Natural antioxidant with anti inflammatory and anti-tumor properties. Also indicated for insomnia, depression, and muscle tension.
Strains to Look For: Pure Kush, White Widow, and El Nino.
Citrusy smell. Researchers are studying its potential anti-tumor properties. Cannabis strains high in limonene are renowned for having an uplifting effect on mood.
Medical Value: Antimicrobial, antifungal and anticancer properties. Has shown efficacy for gastrointestinal disorders.
Strains to Look For: Lemon Skunk, Lemon Haze, Jack the Ripper, and OG Kush
Characterized by a piney scent. This terpene has been used as an antiseptic, antitumor agent, and bronchodilator in many folk-remedy traditions.
Medical Value: For treating asthma and as a natural antiseptic.
Strains to Look For: Trainwreck, Bubba Kush, and Super Silver Haze
Exhibits a peppery/woody aroma. Researchers are investigating the potential of high-caryophyllene strains to treat arthritis and neuropathic pain.
Medical Value: Possible gastroprotective properties. In particular, noted for treating autoimmune conditions like arthritis, ulcers, and depression.
Strains to Look For: Hash Plant and Trainwreck.
Sweet, floral scent. Studies indicate that terpinolene tends to induce drowsiness. It has also been identified as a potential tumor inhibitor.
Medical Value: Has a sedative effect on the central nervous system. Also, believed to have antibacterial, antioxidant, antifungal, and anti-tumor properties.
Strains to Look For: Pineapple Jack, Lemon Sour Diesel, and Super Jack.
Pungent smell reminiscent of fir needles. Animal experiments suggest that camphene may help lower cholesterol.
Medical Value: Research indicates it is natural antibiotic with antiinflammatory properties.
Strains to Look For: Indica strains.
Smells like lilacs. It is believed to have a calming effect as well as antibiotic and antimicrobial properties.
Terpenes are widely recognized as a safe and all-natural way to promote wellness. Increasingly, patients and medical professionals are recognizing the important role they play in medical marijuana, as terpenes can help patients identify the most suitable strains for specific conditions. In addition, their synergistic effect, which magnifies the therapeutic value of cannabinoids and THC, is only beginning to be understood.